Industry NewsNovel diagnostic assay for gastric and gastroesophageal junction cancer receives CE Mark approval
Industry NewsFDA approves OCREVUS ZUNOVO subcutaneous injection for people with relapsing and progressive multiple sclerosis
Product NewsRoche launches new diagnostic test for the better understanding of immune response to SARS-CoV-2
Product NewsRoche launches the VENTANA DP 600 slide scanner for digital pathology, enhancing patient care with precision diagnostics
Product NewsRoche launches comprehensive genomic profiling kit to expand access to personalized cancer research
Industry NewsRoche’s VENTANA PD-L1 Assay receives FDA approval as a companion diagnostic to identify lung cancer patients eligible for Tecentriq (atezolizumab)
Product NewsRoche announced the launch of three molecular PCR diagnostic test panels to detect and differentiate common respiratory pathogens simultaneously
Product NewsRoche receives FDA approval for first companion diagnostic to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy
Industry NewsFDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine
Industry NewsRoche obtains CE mark for the SARS-CoV-2 Antigen Self-Test Nasal allowing for rapid self-testing of COVID-19 at home
Product NewsRoche Launches First Sugar-Transferase for New Glyco-Engineering Portfolio Supporting Applications from Research to Biopharmaceutical Manufacturing
